The Annual General Meeting of Biotest AG took place on May 7, 2024, 10:30 a.m. (CEST), at the Alte Oper Frankfurt, Mozart Saal, Opernplatz, 60313 Frankfurt am Main, Germany.
| Invitation / Agenda of Annual General Meeting 2024 |
|
|
| Overview Information in accordance with Section 125 of the German Stock Corporation Act (AktG) and Regulation (EU) – German Version |
|
|
| Notes on agenda item 1 - German Version | ||
| Information on shareholders' rights - German Version | ||
| Power of attorney for voting power (ordinary shareholders only) - German Version | ||
| Power of attorney for participation at Annual General Meeting (preference shareholders only) – German Version |
|
|
| Total number of shares and voting rights at the time of calling the Annual General Meeting - German Version | ||
| Remuneration Report 2023 |
|
|
| Report of the Supervisory Board | ||
| Annual Report 2023 |
|
|
| Annual financial statements 2023 Biotest AG - German Version |
|
|
| Biotest's articles of association |
|
|
| Dividend Announcement - German Version |
|
|
Here you will find the speech of Peter Janssen from the Annual Shareholders' Meeting:
| Speech of Peter Janssen | ||
| Presentation for the Annual Shareholders Meeting 2024 | ||
Subscribed capital :
39.571.452,00 EUR divided into
19.785.726 ordinary shares
19.785.726 preference shares